TickerSpark Feed

nyse

Everything tagged "nyse" across the TickerSpark archives.

Lyntris Inc. Goes Public: Defense Tech Story to Watch

Lyntris Inc. (NYSE: LYNX) is expected to list on 2026-08-19 at a price range of $19.00 to $22.00 per share. The company is offering 24,000,000 shares, with a disclosed market cap of $607,200,000 if priced at the top of the range. The bull case is a defense-tech platform built around sensing, AI-driven data fusion, and mission systems; the bear case is that key IPO financials and filing details have not been publicly disclosed in the sources found.

Aug 11, 2026·5 MIN

IPO NYSE

IPOCSRA

CSRA Inc. Reappears as an IPO: What the Filing Says

CSRA Inc. is listed as expected to debut on the NYSE on 2026-08-12, but the price range has not been disclosed. The key issue is that the company’s SEC filings show CSRA already filed an S-1 in 2015 and was later acquired in 2018, so investors should watch this calendar entry closely for accuracy before treating it like a fresh IPO.

Aug 11, 2026·4 MIN

IPO NYSE

IPOGAIQ

Guinness Atkinson Funds IPO: The Bull and Bear Case

Guinness Atkinson Funds is expected to list on the NYSE on 2026-08-12, but the price range has not been disclosed. The bigger question is whether this is really an IPO at all, or a routine SEC fund filing for an existing investment company. Bull case: ETF-class expansion in a regulated fund family. Bear case: no IPO economics, no pricing, and no operating-company growth story.

Aug 11, 2026·5 MIN

IPO NYSE

IPOMPDY

What to Watch as Valued Advisers Trust Approaches Listing

Valued Advisers Trust is expected to list on 2026-08-12 on the NYSE, but the price range has not been disclosed. The key issue is that the SEC materials reviewed do not show a traditional operating-company IPO; they describe a long-running registered investment company platform instead. That makes this a watch-the-structure story more than a standard growth IPO.

Aug 11, 2026·5 MIN

IPO NYSE

IPOARIA

ARIAD Pharmaceuticals IPO Preview: Historical Biotech, Current Filing Gap

ARIAD Pharmaceuticals, Inc. (NYSE: ARIA) is expected to list on 2026-08-10, but the price range has not been disclosed. The key question is not valuation yet—it is whether this is a real upcoming IPO filing or a historical company reference that still needs confirmation. Bull case: a recognizable biotech name; bear case: the current offering details are not yet verified.

Aug 7, 2026·5 MIN

IPO NYSE

IPOSNSC

Should You Buy the SunScout Holding Limited IPO? Here's the Setup

SunScout Holding Limited (NYSE: SNSC) is expected to list on 2026-08-07, with shares offered and price range not yet disclosed. The company is a New Zealand-based solar-powered mower and solar solutions business that is still early in its public-market story. Bull case: a niche robotics-and-solar angle; bear case: limited disclosure, small cash balance, and an early-stage structure.

Aug 6, 2026·5 MIN

IPO NYSE

IPOFFLX

Inside the First Trust Exchange-Traded Fund VIII IPO: ETF launch setup

First Trust Exchange-Traded Fund VIII (FFLX) is expected to list on NYSE on 2026-08-10, but the price range has not been disclosed. This looks less like a classic IPO and more like an ETF trust listing with creation/redemption mechanics. Watch whether the fund’s product lineup and fee structure can attract assets in a crowded ETF market.

Aug 2, 2026·4 MIN

IPO NYSE

IPORJCA

What to Watch as Carillon Series Trust Prices on NYSE

Carillon Series Trust is expected to list on 2026-08-03 on the NYSE, but the price range has not been disclosed. The key question is not a classic IPO valuation debate — it is whether this fund platform’s ETF conversion story is compelling enough to attract attention. Bull case: the structure taps the ongoing shift from mutual funds to ETFs. Bear case: this is not a traditional operating-company IPO, so the usual growth and profitability metrics are not available.

Jul 31, 2026·5 MIN

IPO NYSE

IPOARMS

Arm Holdings plc IPO Preview: Licensing Scale Meets China Risk

Arm Holdings plc is expected to list on the NYSE on 2026-07-30, but the price range has not been disclosed. The company’s business is built on licensing CPU architecture and collecting royalties, with a huge ecosystem behind it. Watch whether investors focus on its 97.5% gross margin profile or the heavy customer concentration and China exposure.

Jul 30, 2026·5 MIN

IPO NYSE

IPOREF

Should You Buy the Reformation IPO? Here's the Setup

Reformation Inc. (California) is expected to list on the NYSE under ticker REF on 2026-07-30, with a price range of $15.00 and 14,062,500 shares offered. The deal values the company at $210,937,500 at the indicated terms. The bull case is a profitable, fast-growing sustainable-fashion brand; the bear case is a crowded apparel market with a controlling shareholder still in place.

Jul 30, 2026·5 MIN

IPO NYSE

IPOARMS

Aristotle Funds Series Trust IPO Preview: ETF-Class Ambition Meets Fund Risk

Aristotle Funds Series Trust is expected to list on the NYSE on 2026-07-30, but the price range has not been disclosed. The setup is less a classic operating-company IPO and more a fund-platform listing tied to ETF-style expansion.

Jul 29, 2026·5 MIN

IPO NYSE

IPOWSMD

Wasatch Funds Trust IPO Preview: Active Small-Cap Scale Meets Structure Questions

Wasatch Funds Trust is expected to list on the NYSE on 2026-07-29, but the price range has not been disclosed and shares offered are still not public. The setup is less a classic operating-company IPO and more a check on whether investors want exposure to a long-running active fund platform. Shareholders should watch the structure closely, because the filing trail does not look like a standard common-stock offering.